The aim of this study was to assess heart rate variability, a noninvasive parameter for studying the neurohumoral control of heart rate, in children with atrial septal defect. We examined five time-domain and three frequency-domain indices of heart rate variability determined from 24-hour Holter recordings in 20 children, aged 3–14 years, with secundum atrial septal defect who were about to undergo operation. The measures were compared to normal ranges and to the hemodynamic data of the preoperative cardiac catheterization. Most indices of heart rate variability were moderately depressed in children with atrial septal defect. Our data revealed negative correlations between indices and the mean right atrial pressure and the enddiastolic right ventricular pressure, respectively. The study demonstrates the importance of the right ventricular filling pressures for the autonomic control of the heart in children with atrial septal defect.

1.
Eckberg DL, Drabinsky M, Braunwald E: Defective parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877–883.
2.
Kienzle MG, Ferguson DW, Birkett CL, Myers GA, Berg WJ, Mariano DJ: Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992;69:761–767.
3.
Packer M: Neurohumoral interactions and adaptations in congestive heart failure. Circulation 1988;77:721–730.
4.
Parmley WW: Pathophysiology of congestive heart failure. Am J Cardiol 1985;56:7A–11A.
5.
Rutenberg HL, Spann JF: Alterations of cardiac sympathetic neurotransmitter activity in congestive heart failure. Am J Cardiol 1973;32:472–480.
6.
Massin M, von Bernuth G: Clinical and haemodynamic correlates of heart rate variability in children with congenital heart disease. Eur J Pediatr 1998;157:967–971.
7.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043–1065.
8.
Massin M, von Bernuth G: Normal ranges of heart rate variability during infancy and childhood. Pediatr Cardiol 1997;18:297–302.
9.
Davies LG, Fotiades B: Sinus arrhythmia: Observations in atrial septal defect and normal subjects. Br Heart J 1960;22:301.
10.
Finley JP, Nugent ST, Hellenbrand W, Craig M, Gillis DA: Sinus arrhythmia in children with atrial septal defect: An analysis of heart rate variability before and after surgical repair. Br Heart J 1989;61:280–284.
11.
Horner SM, Murphy CF, Dick DJ, Zhou B, Harrison FG, Lab MJ: The effect of stretch on the sinoatrial node – A physiological mechanism contributing to heart rate variability. Br Heart J 1994;71(suppl):P90.
12.
Melcher A: Respiratory sinus arrhythmia in man: A study in heart-regulating mechanisms. Acta Physiol Scand Suppl 1976;435:1–31.
13.
Levin AR, Spach MS, Boineau JP, Canent RV Jr, Capp MP, Jewett PH: Atrial pressure-flow dynamics in atrial septal defects (secundum type). Circulation 1968;37:476–488.
14.
Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC Jr: Atrial stretch, not pressure, is the principal determinant controlling in the acute release of atrial natriuretic factor. Circ Res 1988;62:191–195.
15.
Lewis BS, Makhoul N, Dakak N, Flugelman MY, Yechiely H, Halon DA, Kahana L: Atrial natriuretic peptide in severe heart failure: Response to controlled changes in atrial pressure during intravenous nitroglycerin therapy. Am Heart J 1992;124:1009–1016.
16.
Showalter CJ, Zimmerman RS, Schwab TR, Edwards BS, Opgenorth TJ, Burnett JC Jr: Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol 1988;254:R453–R456.
17.
Morgan DA, Pueler JD, Koepke JP, Mark AL, DiBona GF: Renal sympathetic nerves attenuate the natriuretic effects of atrial peptide. J Lab Clin Med 1989;114:538–544.
18.
McMurray JJ, Seidelin PH, Brown RA, Struthers AD: Noradrenaline attenuates the natriuretic effect of atrial natriuretic factor in man. Br J Clin Pharmacol 1989;27:7–12.
19.
Hirsch AT, Dzau VJ, Creager MA: Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation 1987;75(suppl IV):36–48.
20.
Goldsmith SR, Francis GS, Levine TB, Cohn JN: Regional blood flow response to orthostasis in patients with congestive heart failure. J Am Coll Cardiol 1983;1:1391–1395.
21.
Creager MA, Faxon DP, Rockwell SM, Gavras H, Coffman JD: The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: Observations during orthostasis and alpha-adrenergic blockade. Clin Sci 1985;68:659–667.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.